Cargando…
Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
During the COVID-19 pandemic, EPI-PHARE, a scientific group in pharmaco-epidemiology created by the French National Agency for the Safety of Medicines and Health Products (ANSM) and the French National Health Insurance (Cnam), has reoriented its work program to enlighten health authorities in this h...
Autores principales: | Zureik, Mahmoud, Cuenot, François, Weill, Alain, Dray-Spira, Rosemary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851737/ https://www.ncbi.nlm.nih.gov/pubmed/36739224 http://dx.doi.org/10.1016/j.therap.2022.12.013 |
Ejemplares similares
-
Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023) -
Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France
por: Roland, Noémie, et al.
Publicado: (2021) -
Colonoscopy in France during the COVID-19 pandemic
por: Meyer, Antoine, et al.
Publicado: (2021) -
Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France
por: Roland, Noémie, et al.
Publicado: (2022) -
Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
por: Semenzato, Laura, et al.
Publicado: (2021)